New report published by Global Info Research which offers insights on the global Anthrax Vaccines market.
Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.
Click to view the full report TOC, figure and tables:
Global Anthrax Vaccines Market: Forecast by Type / Application / Region
Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.
Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax.
This report studies Anthrax Vaccines in Global market, especially in North America, Europe, China, South America, RoA, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturers covering: Emergent BioSolutions, Merial, Merck, Zoetis , Bayer Sanidad Animal, Colorado Serum, PharmAthene, Tiankang, Biogénesis-Bago, CAVAC, Rosenbusch, Agrovet, Vecol, CVCRI, IVPM, Prondil, CDV, Indian Immunologicals, Botswana Vaccine Institute, Ceva Santé Animale, Intervac and JOVAC.
Split by Product Type, with production, revenue, price, and market share and growth rate of each types be divided into: Live Vaccines and Cell free PA Vaccines.
Split by application, this report focuses on sales, market share and growth rate of Anthrax Vaccines in each applications can be divided into: Human Use and Animal Use.
In the last several years, global market of Anthrax Vaccines developed rapidly, with an average growth rate of 7.6 %. In 2016, global revenue of Anthrax Vaccines is nearly 470 million USD; the actual production is about 540 million Doses.
Along with the development of China ‘s Agricultural technology, there is a lot Chinese local manufacturer can produce Anthrax Vaccines, with the increasing demand, more and more manufactures will go into Anthrax Vaccines industry.
The classification of Anthrax Vaccines includes Live Vaccines and Cell free PA Vaccines, and the revenue proportion of Live Vaccines in 2016 is about 43%.
Anthrax Vaccines are widely used for human and animal. The most proportion of Anthrax Vaccines is used for animal, and the consumption proportion is about 95.1% in 2016.
South America region is the largest supplier of Anthrax Vaccines, with a production market share nearly 34.7% in 2016. Europe is the second largest supplier of Anthrax Vaccines, enjoying production market share nearly 17.6% in 2016.
South America is the largest sales place, with a sales market share nearly 39.3% in 2016. Following South America, Europe is the second largest sales place with the sales market share of 19.1%.
Market competition is intense. Emergent BioSolutions is the major manufacturer of Anthrax Vaccines used for human, Merial, Merck, Zoetis, Bayer Sanidad Animal,Colorado Serum, etc. are is the major manufacturer of Anthrax Vaccines used for animal, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Ask for Discount on Research Report and Request Sample Copy of Report@
GlobalInfoResearch is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.
United States Anthrax Vaccines Market 2018 Forecast to 2023
Europe Anthrax Vaccines Market 2018 Forecast to 2023
North America Anthrax Vaccines Market 2018 Forecast to 2023
Asia-Pacific Anthrax Vaccines Market 2018 Forecast to 2023
China Anthrax Vaccines Market 2018 Forecast to 2023
EMEA Anthrax Vaccines Market 2018 Forecast to 2023
Global Anthrax Vaccines Market 2018 Forecast to 2023
Contact US :
Sales Director (Global Info Research)
Tel: +86-15521064060 00852-58197708(HK)
Add: RM 1605C HO KING COMM CTR 2-16 FA YUEN ST MONGKOK KL Hong Kong